TTY Biopharm Company Limited
TWO: 4105.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Kuo-Chiang Chang
- Employees
- 561
- Headquarters
- Taipei, Taiwan
- IPO year
- 2007
- Market cap
- NT$18.7B
- Website
- https://www.tty.com.tw
Loading 4105…
Loading profile data…Frequently asked questions about 4105
What does TTY Biopharm Company Limited (4105.TWO) do?
TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, and Other Business Unit segments. It offe...
Where does 4105.TWO trade?
TTY Biopharm Company Limited (4105.TWO) trades on the Taipei Exchange.
What sector is 4105.TWO in?
TTY Biopharm Company Limited (4105.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of TTY Biopharm Company Limited?
Kuo-Chiang Chang is the chief executive officer of TTY Biopharm Company Limited (4105.TWO).
Where is TTY Biopharm Company Limited headquartered?
TTY Biopharm Company Limited is headquartered in Taiwan.
Does 4105.TWO pay a dividend?
Yes — TTY Biopharm Company Limited (4105.TWO) paid a trailing twelve-month dividend of TWD 4.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4105.TWO go public?
TTY Biopharm Company Limited (4105.TWO) completed its initial public offering in 2007.